抗胆碱能药物对烧伤患者感觉恢复:有益还是有害?
本研究基于TriNetX数据库回顾性分析烧伤时使用抗胆碱能药物与感觉恢复的关联。按解剖区域编码的362224例中匹配9266对,用药组感觉异常风险为对照组的2.19倍(95%CI 1.85-2.60),镇痛药使用更高。按TBSA编码的168164例中3294对结果相似,提示可能反映神经再生但也可致异常疼痛。
要点
- 烧伤时使用抗胆碱能药物与感觉异常风险升高相关,按解剖区域编码RR 2.19。
- 按TBSA编码分析显示相似趋势,感觉异常RR 2.95,镇痛药使用亦增加。
- 感觉异常可能反映神经再生,但也可能是异常或疼痛感觉,需进一步评估功能结局。
核心结论
- 烧伤患者使用抗胆碱能治疗更可能发生感觉异常,可能提示神经再生,但也可能导致异常或疼痛感觉而影响生活质量,需进一步研究功能结局。
研究设计与样本
- 回顾性分析,使用TriNetX研究数据库,按ICD-10-CM解剖区域和总烧伤表面积(TBSA)识别烧伤患者。
- 实验组为烧伤时服用七种抗胆碱能药物之一(达非那新、非索罗定、奥昔布宁、丙哌维林、索利那新、托特罗定或曲司氯铵)的患者,对照组为未用这些药物的烧伤患者,排除既往感觉障碍者。
- 按年龄、性别、糖尿病状态及烧伤部位或TBSA进行倾向评分匹配,以伤后3-24个月感觉异常作为神经再生的替代指标。
- 按解剖区域编码的362224例烧伤患者中,9266例抗胆碱能使用者匹配9266例对照;按TBSA编码的168164例中匹配3294对。
主要发现
- 按解剖区域编码分析:抗胆碱能使用者发生感觉异常的风险为对照组的2.19倍(RR 2.19,95%CI 1.85-2.60),镇痛药使用率52.4% vs 30.3%(p < 0.001)。
- 按TBSA编码分析:匹配3294对,感觉异常风险为对照组的2.95倍(RR 2.95,95%CI 2.06-4.23),镇痛药使用率50.1% vs 25.3%(p < 0.001)。
临床怎么用
- 烧伤患者使用抗胆碱能药物时需关注感觉异常的发生,权衡可能的神经再生益处与异常疼痛风险。
- 当前证据不足以支持将抗胆碱能药物用于促进烧伤后感觉恢复,需进一步研究功能结局。
局限性
- 回顾性研究设计,以感觉异常作为神经再生的替代指标,可能受混杂因素影响。
- 需进一步研究评估功能结局,原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Burn injuries are a major cause of morbidity and mortality, often resulting in nerve damage that causes pain or numbness. Loss of protective sensation increases the risk of future injury. Enhancing nerve regeneration after burns is critical. Antimuscarinic drugs, used to treat overactive bladder, have shown potential in promoting peripheral nerve growth by supporting cytoskeletal development and mitochondrial trafficking. This study investigates whether antimuscarinic use at the time of burn injury is associated with increased nerve regeneration. METHODS: We conducted a retrospective analysis using the TriNetX Research Database. Burn patients were identified using ICD-10-CM codes by anatomical area and total burn surface area (TBSA). The experimental group included patients taking one of seven antimuscarinic drugs (darifenacin, fesoterodine, oxybutynin, propiverine, solifenacin, tolterodine, or trospium) at the time of injury. Controls were burn patients not on these medications. Patients with preexisting sensory disturbances were excluded. Propensity score matching was performed by age, sex, diabetes status, and either burn location or TBSA. Paresthesia 3-24 months post-injury was used as a proxy for nerve regeneration. RESULTS: Among 362,224 patients with burns coded by anatomical area, 9266 antimuscarinic users were matched to 9266 controls. Users were over twice as likely to develop paresthesia (RR: 2.19, CI: [1.85, 2.60]) and had higher analgesic use (52.4 % vs. 30.3 %, p < 0.001). For 168,164 patients with burns coded by TBSA, 3294 matched pairs showed similar findings: increased paresthesia (RR: 2.95, CI: [2.06, 4.23]) and analgesic use (50.1 % vs. 25.3 %, p < 0.001). CONCLUSION: Burn patients on antimuscarinic therapy were more likely to develop paresthesia, possibly indicating nerve regeneration. While this may reflect sensory recovery, it could also lead to abnormal or painful sensations that negatively impact quality of life. Further research is needed to assess functional outcomes.
引用
- Zamore ZH, Khong J, Suresh R, et al. Antimuscarinics for burn patients: Helpful or harmful for sensation recovery? Burns. 2025. PMID: 40834487. doi:10.1016/j.burns.2025.107632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。